The estimated Net Worth of David Linetsky is at least $12.3 Million dollars as of 16 July 2024. Mr Linetsky owns over 1,820 units of Phreesia Inc stock worth over $4,715,724 and over the last 5 years he sold PHR stock worth over $7,015,905. In addition, he makes $578,458 as Sr. VP of Life Sciences at Phreesia Inc.
Mr has made over 34 trades of the Phreesia Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 1,820 units of PHR stock worth $43,207 on 16 July 2024.
The largest trade he's ever made was selling 50,060 units of Phreesia Inc stock on 15 March 2021 worth over $3,058,666. On average, Mr trades about 6,641 units every 31 days since 2019. As of 16 July 2024 he still owns at least 202,218 units of Phreesia Inc stock.
You can see the complete history of Mr Linetsky stock trades at the bottom of the page.
David Linetsky is the Sr. VP of Life Sciences at Phreesia Inc.
As the Sr. VP of Life Sciences of Phreesia Inc, the total compensation of Mr Linetsky at Phreesia Inc is $578,458. There are 4 executives at Phreesia Inc getting paid more, with Chaim Indig having the highest compensation of $10,474,400.
Mr Linetsky is 42, he's been the Sr. VP of Life Sciences of Phreesia Inc since . There are 12 older and 3 younger executives at Phreesia Inc. The oldest executive at Phreesia Inc is Mark Smith, 68, who is the Independent Director.
David's mailing address filed with the SEC is C/O PHREESIA, 1521 CONCORD PIKE, SUITE 301 PMB 221, WILMINGTON, DE, 19803.
Over the last 5 years, insiders at Phreesia Inc have traded over $277,935,884 worth of Phreesia Inc stock. The most active insiders traders include Edward L Cahill, Venture Partners Ii, L.P.Hl..., and Scott Perricelli. On average, Phreesia Inc executives and independent directors trade stock every 8 days with the average trade being worth of $1,320,099. The most recent stock trade was executed by Allison C Hoffman on 26 August 2024, trading 14,110 units of PHR stock currently worth $367,283.
leading healthcare organizations choose phreesia to revolutionize their point of service. in medical groups of all sizes, phreesia’s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.
Phreesia Inc executives and other stock owners filed with the SEC include: